INVION LIMITED - Announcements

4.17%

10.0¢

Market Cap $8.541M

Healthcare Biotechnology

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IVX	Change of Director's Interest Notice - Thian Chew		28/10/20	161.08KB	Share
IVX	Change of Director's Interest Notice - Alan Yamashita		28/10/20	160.53KB	Share
IVX	Appendix 3G		28/10/20	276.72KB	Share
IVX	Appendix 3G		28/10/20	275.06KB	Share
IVX	Initial Director's Interest Notice		28/10/20	217.7KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	26/10/20	467.65KB	Share
IVX	Director Appointment		26/10/20	178.96KB	Share
IVX	Results of Annual General Meeting		21/10/20	171.47KB	Share
IVX	AGM Presentation		21/10/20	749.91KB	Share
IVX	Grant of ASX Waiver		21/09/20	114.89KB	Share
IVX	Proxy Form		21/09/20	143.92KB	Share
IVX	Notice of Annual General Meeting		21/09/20	519.43KB	Share
IVX	Appendix 3G - issue of options		14/09/20	267.42KB	Share
IVX	Appendix 3G - issue of options		02/09/20	267.46KB	Share
IVX	Initial Director's Interest Notice		02/09/20	151.23KB	Share
IVX	Lapse of unlisted options		01/09/20	122.39KB	Share
IVX	Final Director's Interest Notice		01/09/20	148.86KB	Share
IVX	Director Appointment/Resignation		01/09/20	129.3KB	Share
IVX	Appendix 4G and Corporate Governance Statement		26/08/20	447.22KB	Share
IVX	Appendix 4E and Annual Report	PRICE SENSITIVE	26/08/20	1.09MB	Share
IVX	Cleansing Notice and Appendix 2A		12/08/20	390.12KB	Share
IVX	Change of Company Addresses		07/08/20	123.51KB	Share
IVX	Business Update and Change to Board and Management	PRICE SENSITIVE	29/07/20	101.61KB	Share
IVX	Activities Report and Appendix 4C June 2020 Quarter	PRICE SENSITIVE	29/07/20	389.86KB	Share
IVX	Appointment of M Leydin as Chief Financial Officer		13/07/20	118.69KB	Share
IVX	Invion subsidiary signs Supply Agreement with Pavay Biotech	PRICE SENSITIVE	30/06/20	91.05KB	Share
IVX	Acceptance of New Zealand Patent Application		23/06/20	81.33KB	Share
IVX	Program Update - March 2020 quarter		20/04/20	4.25MB	Share
IVX	Appendix 4C - March 2020 quarter	PRICE SENSITIVE	20/04/20	1.1MB	Share
IVX	Preliminary data links Photosoft with immune response		15/04/20	100.81KB	Share
IVX	App 4D and Financial Report for half year to 31 Dec 2019	PRICE SENSITIVE	24/02/20	321.09KB	Share
IVX	Photosoft data presented to Lorne Cancer Conference		14/02/20	247.28KB	Share
IVX	Clarification to announcements of 3 February 2020		05/02/20	237.45KB	Share
IVX	Lapse of unlisted share options		03/02/20	227.26KB	Share
IVX	Invion signs R&D Services Agreement with Pavay Biotech	PRICE SENSITIVE	03/02/20	250.76KB	Share
IVX	Appendix 4C December 2019 - cover note and market update		30/01/20	85.29KB	Share
IVX	Appendix 4C - December 2019 quarter	PRICE SENSITIVE	30/01/20	1019.02KB	Share
IVX	App 3Z - Campbell - correction to date ceased to be director		09/01/20	255.39KB	Share
IVX	MoU with Pavay on potential supply of dermatology compound		24/12/19	227.91KB	Share
IVX	Final Directors Interest Notice - Campbell		23/12/19	192.89KB	Share
IVX	Initial Directors Interest Notice - Farris		23/12/19	364.03KB	Share
IVX	Change in Board and Management		23/12/19	229.76KB	Share
IVX	Additional Information to Prior Announcement	PRICE SENSITIVE	29/11/19	140.76KB	Share
IVX	Photosoft technology shrinks ovarian cancer in vivo		27/11/19	94.16KB	Share
IVX	App 3X - Initial Directors Interest Notice - C Newton		04/11/19	363.75KB	Share
IVX	App 3Z - Director's Final Interests Notice - G Collier		04/11/19	192.94KB	Share
IVX	Results of AGM		04/11/19	290.72KB	Share
IVX	App 3Y - Change of Directors Interest Notice - G Collier		04/11/19	227.15KB	Share
IVX	Chairman's Address and CEO Presentation to Board		04/11/19	2.42MB	Share
IVX	Appendix 3B - issue of options to incoming CEO		31/10/19	553.18KB	Share
IVX	Pre-clinical research agreement with Peter MacCallum CC	PRICE SENSITIVE	31/10/19	255.32KB	Share
IVX	Appendix 4C - September 2019 quarter	PRICE SENSITIVE	29/10/19	20.75KB	Share
IVX	C Newton to commence as CEO - Material terms of appointment		24/10/19	228.03KB	Share
IVX	AGM Notice of Meeting		03/10/19	206.78KB	Share
IVX	Investor Update - September 2019		30/09/19	9.11MB	Share
IVX	Invion optimises PDT therapy and laser for 2020 human trials		30/09/19	86.28KB	Share
IVX	Corporate Governance Statement		28/08/19	135.75KB	Share
IVX	Appendix 4G		28/08/19	108.14KB	Share
IVX	Appendix 4E and Financial Report for year ended 30 June 2019	PRICE SENSITIVE	28/08/19	862.79KB	Share
IVX	Change in substantial holding		15/08/19	254.67KB	Share
IVX	COO Craig Newton to transition to Invion CEO	PRICE SENSITIVE	22/07/19	82.2KB	Share
IVX	Appendix 4C - June quarter	PRICE SENSITIVE	12/07/19	166.56KB	Share
IVX	Animal studies show IVX-P02 potential in metastatic cancers	PRICE SENSITIVE	28/05/19	84.29KB	Share
IVX	Quarterly Update	PRICE SENSITIVE	18/04/19	82.04KB	Share
IVX	Appendix 4C - March 2019 quarter	PRICE SENSITIVE	18/04/19	20.42KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	01/04/19	435.41KB	Share
IVX	Corporate update to support BD and investor meetings		28/02/19	73.1KB	Share
IVX	Corporate Update and Investor Presentation - Q1 2019		28/02/19	2.33MB	Share
IVX	Appendix 4D and Financial Report for Half Year to 31 Dec 18	PRICE SENSITIVE	26/02/19	317.82KB	Share
IVX	Shareholder Q&A on spinout of Chronic Airway Therapeutics		21/02/19	88.4KB	Share
IVX	Response to ASX Appendix 4C Query	PRICE SENSITIVE	21/02/19	438.11KB	Share
IVX	App 3Y Change in Director Interests - T Chew		18/02/19	69.69KB	Share
IVX	App 3Y Change in Director Interests - G Collier		18/02/19	71.52KB	Share
IVX	App 3Y Change in Director Interests - J Campbell		18/02/19	69.83KB	Share
IVX	App 3X Initial Directors Interest Notice - A Yamashita		18/02/19	112.96KB	Share
IVX	App 3Z Final Directors Interest Notice - M Glass		18/02/19	60.15KB	Share
IVX	Appendix 3B - issue of shares and unlisted share options		12/02/19	149.97KB	Share
IVX	Invion completes spin-out of respiratory assets	PRICE SENSITIVE	12/02/19	83.2KB	Share
IVX	General Meeting - Results of Meeting	PRICE SENSITIVE	30/01/19	136.23KB	Share
IVX	CEO Update to General Meeting		30/01/19	6MB	Share
IVX	Invion selects Guilin Xingda for light-therapy manufacture		29/01/19	81.87KB	Share
IVX	Appendix 4C - December quarter	PRICE SENSITIVE	29/01/19	172.82KB	Share
IVX	Invion appoints cancer experts to Scientific Advisory Board		16/01/19	84.52KB	Share
IVX	Appendix 3Y - Change in Director Interests - Thian Chew		24/12/18	69.06KB	Share
IVX	General Meeting - Notice of Meeting		21/12/18	361.34KB	Share
IVX	Respiratory Assets Demerger - Receipt of draft Class Ruling		21/12/18	79.35KB	Share
IVX	Appendix 3Y - Change in Director Interests - Thian Chew		14/12/18	69.12KB	Share
IVX	Demerger of respiratory assets - update		29/11/18	87.54KB	Share
IVX	Ceasing to have an interest over shares		19/11/18	174.41KB	Share
IVX	Appendix 3B - lapse of unlisted share options		19/11/18	144.2KB	Share
IVX	Notification regarding release of escrowed securities		19/11/18	73.83KB	Share
IVX	Invion Constitution adopted 13 November 2018		16/11/18	269.64KB	Share
IVX	Annual General Meeting - Results of Meeting		13/11/18	129.32KB	Share
IVX	Chairman's Address and CEO Presentation to AGM		13/11/18	10.68MB	Share
IVX	Invion collaborates to develop powerful skin cancer gel		07/11/18	88.89KB	Share
IVX	Appendix 4C - September 2018 quarter	PRICE SENSITIVE	29/10/18	95.8KB	Share
IVX	CAT appoints R&G Pharma as CRO for nadolol in China		27/09/18	84.71KB	Share
IVX	New Photosoft formulation increased effect in ovarian cancer	PRICE SENSITIVE	25/09/18	87.07KB	Share
IVX	AGM Notice of Meeting		24/09/18	352.95KB	Share
IVX	Photosoft granted Australian patent and Business Update		10/09/18	94.69KB	Share

IVX Change of Director's Interest Notice - Thian Chew
28/10/20		161.08KB	Share
IVX Change of Director's Interest Notice - Alan Yamashita
28/10/20		160.53KB	Share
IVX Appendix 3G
28/10/20		276.72KB	Share
IVX Appendix 3G
28/10/20		275.06KB	Share
IVX Initial Director's Interest Notice
28/10/20		217.7KB	Share
IVX Activities Report and Appendix 4C
26/10/20	PRICE SENSITIVE	467.65KB	Share
IVX Director Appointment
26/10/20		178.96KB	Share
IVX Results of Annual General Meeting
21/10/20		171.47KB	Share
IVX AGM Presentation
21/10/20		749.91KB	Share
IVX Grant of ASX Waiver
21/09/20		114.89KB	Share
IVX Proxy Form
21/09/20		143.92KB	Share
IVX Notice of Annual General Meeting
21/09/20		519.43KB	Share
IVX Appendix 3G - issue of options
14/09/20		267.42KB	Share
IVX Appendix 3G - issue of options
02/09/20		267.46KB	Share
IVX Initial Director's Interest Notice
02/09/20		151.23KB	Share
IVX Lapse of unlisted options
01/09/20		122.39KB	Share
IVX Final Director's Interest Notice
01/09/20		148.86KB	Share
IVX Director Appointment/Resignation
01/09/20		129.3KB	Share
IVX Appendix 4G and Corporate Governance Statement
26/08/20		447.22KB	Share
IVX Appendix 4E and Annual Report
26/08/20	PRICE SENSITIVE	1.09MB	Share
IVX Cleansing Notice and Appendix 2A
12/08/20		390.12KB	Share
IVX Change of Company Addresses
07/08/20		123.51KB	Share
IVX Business Update and Change to Board and Management
29/07/20	PRICE SENSITIVE	101.61KB	Share
IVX Activities Report and Appendix 4C June 2020 Quarter
29/07/20	PRICE SENSITIVE	389.86KB	Share
IVX Appointment of M Leydin as Chief Financial Officer
13/07/20		118.69KB	Share
IVX Invion subsidiary signs Supply Agreement with Pavay Biotech
30/06/20	PRICE SENSITIVE	91.05KB	Share
IVX Acceptance of New Zealand Patent Application
23/06/20		81.33KB	Share
IVX Program Update - March 2020 quarter
20/04/20		4.25MB	Share
IVX Appendix 4C - March 2020 quarter
20/04/20	PRICE SENSITIVE	1.1MB	Share
IVX Preliminary data links Photosoft with immune response
15/04/20		100.81KB	Share
IVX App 4D and Financial Report for half year to 31 Dec 2019
24/02/20	PRICE SENSITIVE	321.09KB	Share
IVX Photosoft data presented to Lorne Cancer Conference
14/02/20		247.28KB	Share
IVX Clarification to announcements of 3 February 2020
05/02/20		237.45KB	Share
IVX Lapse of unlisted share options
03/02/20		227.26KB	Share
IVX Invion signs R&D Services Agreement with Pavay Biotech
03/02/20	PRICE SENSITIVE	250.76KB	Share
IVX Appendix 4C December 2019 - cover note and market update
30/01/20		85.29KB	Share
IVX Appendix 4C - December 2019 quarter
30/01/20	PRICE SENSITIVE	1019.02KB	Share
IVX App 3Z - Campbell - correction to date ceased to be director
09/01/20		255.39KB	Share
IVX MoU with Pavay on potential supply of dermatology compound
24/12/19		227.91KB	Share
IVX Final Directors Interest Notice - Campbell
23/12/19		192.89KB	Share
IVX Initial Directors Interest Notice - Farris
23/12/19		364.03KB	Share
IVX Change in Board and Management
23/12/19		229.76KB	Share
IVX Additional Information to Prior Announcement
29/11/19	PRICE SENSITIVE	140.76KB	Share
IVX Photosoft technology shrinks ovarian cancer in vivo
27/11/19		94.16KB	Share
IVX App 3X - Initial Directors Interest Notice - C Newton
04/11/19		363.75KB	Share
IVX App 3Z - Director's Final Interests Notice - G Collier
04/11/19		192.94KB	Share
IVX Results of AGM
04/11/19		290.72KB	Share
IVX App 3Y - Change of Directors Interest Notice - G Collier
04/11/19		227.15KB	Share
IVX Chairman's Address and CEO Presentation to Board
04/11/19		2.42MB	Share
IVX Appendix 3B - issue of options to incoming CEO
31/10/19		553.18KB	Share
IVX Pre-clinical research agreement with Peter MacCallum CC
31/10/19	PRICE SENSITIVE	255.32KB	Share
IVX Appendix 4C - September 2019 quarter
29/10/19	PRICE SENSITIVE	20.75KB	Share
IVX C Newton to commence as CEO - Material terms of appointment
24/10/19		228.03KB	Share
IVX AGM Notice of Meeting
03/10/19		206.78KB	Share
IVX Investor Update - September 2019
30/09/19		9.11MB	Share
IVX Invion optimises PDT therapy and laser for 2020 human trials
30/09/19		86.28KB	Share
IVX Corporate Governance Statement
28/08/19		135.75KB	Share
IVX Appendix 4G
28/08/19		108.14KB	Share
IVX Appendix 4E and Financial Report for year ended 30 June 2019
28/08/19	PRICE SENSITIVE	862.79KB	Share
IVX Change in substantial holding
15/08/19		254.67KB	Share
IVX COO Craig Newton to transition to Invion CEO
22/07/19	PRICE SENSITIVE	82.2KB	Share
IVX Appendix 4C - June quarter
12/07/19	PRICE SENSITIVE	166.56KB	Share
IVX Animal studies show IVX-P02 potential in metastatic cancers
28/05/19	PRICE SENSITIVE	84.29KB	Share
IVX Quarterly Update
18/04/19	PRICE SENSITIVE	82.04KB	Share
IVX Appendix 4C - March 2019 quarter
18/04/19	PRICE SENSITIVE	20.42KB	Share
IVX Response to ASX Price Query
01/04/19	PRICE SENSITIVE	435.41KB	Share
IVX Corporate update to support BD and investor meetings
28/02/19		73.1KB	Share
IVX Corporate Update and Investor Presentation - Q1 2019
28/02/19		2.33MB	Share
IVX Appendix 4D and Financial Report for Half Year to 31 Dec 18
26/02/19	PRICE SENSITIVE	317.82KB	Share
IVX Shareholder Q&A on spinout of Chronic Airway Therapeutics
21/02/19		88.4KB	Share
IVX Response to ASX Appendix 4C Query
21/02/19	PRICE SENSITIVE	438.11KB	Share
IVX App 3Y Change in Director Interests - T Chew
18/02/19		69.69KB	Share
IVX App 3Y Change in Director Interests - G Collier
18/02/19		71.52KB	Share
IVX App 3Y Change in Director Interests - J Campbell
18/02/19		69.83KB	Share
IVX App 3X Initial Directors Interest Notice - A Yamashita
18/02/19		112.96KB	Share
IVX App 3Z Final Directors Interest Notice - M Glass
18/02/19		60.15KB	Share
IVX Appendix 3B - issue of shares and unlisted share options
12/02/19		149.97KB	Share
IVX Invion completes spin-out of respiratory assets
12/02/19	PRICE SENSITIVE	83.2KB	Share
IVX General Meeting - Results of Meeting
30/01/19	PRICE SENSITIVE	136.23KB	Share
IVX CEO Update to General Meeting
30/01/19		6MB	Share
IVX Invion selects Guilin Xingda for light-therapy manufacture
29/01/19		81.87KB	Share
IVX Appendix 4C - December quarter
29/01/19	PRICE SENSITIVE	172.82KB	Share
IVX Invion appoints cancer experts to Scientific Advisory Board
16/01/19		84.52KB	Share
IVX Appendix 3Y - Change in Director Interests - Thian Chew
24/12/18		69.06KB	Share
IVX General Meeting - Notice of Meeting
21/12/18		361.34KB	Share
IVX Respiratory Assets Demerger - Receipt of draft Class Ruling
21/12/18		79.35KB	Share
IVX Appendix 3Y - Change in Director Interests - Thian Chew
14/12/18		69.12KB	Share
IVX Demerger of respiratory assets - update
29/11/18		87.54KB	Share
IVX Ceasing to have an interest over shares
19/11/18		174.41KB	Share
IVX Appendix 3B - lapse of unlisted share options
19/11/18		144.2KB	Share
IVX Notification regarding release of escrowed securities
19/11/18		73.83KB	Share
IVX Invion Constitution adopted 13 November 2018
16/11/18		269.64KB	Share
IVX Annual General Meeting - Results of Meeting
13/11/18		129.32KB	Share
IVX Chairman's Address and CEO Presentation to AGM
13/11/18		10.68MB	Share
IVX Invion collaborates to develop powerful skin cancer gel
07/11/18		88.89KB	Share
IVX Appendix 4C - September 2018 quarter
29/10/18	PRICE SENSITIVE	95.8KB	Share
IVX CAT appoints R&G Pharma as CRO for nadolol in China
27/09/18		84.71KB	Share
IVX New Photosoft formulation increased effect in ovarian cancer
25/09/18	PRICE SENSITIVE	87.07KB	Share
IVX AGM Notice of Meeting
24/09/18		352.95KB	Share
IVX Photosoft granted Australian patent and Business Update
10/09/18		94.69KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change 0.004(4.17%)		Mkt cap ! $8.541M

Open	High	Low	Value	Volume
9.7¢	10.0¢	9.6¢	$6.613K	66.75K

Buyers (Bids)

No.	Vol.	Price($)
1	75887	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	294638	3

View Market Depth

No.	Vol.	Price($)
1	75887	0.096
2	60000	0.095
1	47000	0.094
1	25000	0.093
1	42667	0.092

Price($)	Vol.	No.
0.100	294638	3
0.105	22162	2
0.110	28153	1
0.115	58455	2
0.120	20233	2

Last trade - 15.14pm 30/07/2025 (20 minute delay)

IVX (ASX) Chart

INVION LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available